国: オーストラリア
言語: 英語
ソース: Department of Health (Therapeutic Goods Administration)
estriol, Quantity: 1 mg
Aspen Pharmacare Australia Pty Ltd
Tablet, uncoated
Excipient Ingredients: amylopectin; potato starch; lactose monohydrate; magnesium stearate
Oral
30 tablets
Medicine Registered
(S4) Prescription Only Medicine
Short-term treatment of menopausal syndrome. Review the need for continuation of treatment after 6 months treatment, taking into account the risk-benefit ratio for the individual user at that moment (including cardiovascular disease and breast cancer, refer to clinical trials and precautions). Ovestin tablets should only be continued for as long as the benefit outweighs the risks.
Visual Identification: white flat round tablet with bevelled edges and a single breakline. Coded DG above 7 on one side, below the score line.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 4 Years; Container Temperature: Store below 30 degrees Celsius
Registered
1991-09-20
OVESTIN ® TABLETS 1 OVESTIN ® TABLETS _estriol 1 mg_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Ovestin tablets. It does not contain all the available information and it does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Ovestin Tablets against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST KEEP THIS LEAFLET. You may need to read it again. WHAT OVESTIN TABLETS ARE USED FOR Ovestin tablets is a Hormone Replacement Therapy (HRT). It contains the female hormone oestriol (an oestrogen). Ovestin is used in postmenopausal women with at least 12 months since their last natural period. Ovestin is used for relief of symptoms occurring after menopause. During menopause, the amount of oestrogens produced by a woman's body gradually drops. If the ovaries are removed surgically (ovariectomy) before menopause, the decrease in oestrogen production occurs very abruptly. In many cases the decrease in oestrogen production leads to well-known menopausal complaints such as hot flushes and night sweating. The shortage of oestrogens may cause the vaginal wall to become thin and dry. As a result sexual intercourse become painful and vaginal itching and infections may occur. Oestrogen deficiency may also lead to symptoms like urinary incontinence and recurrent cystitis. Ovestin alleviates these symptoms after menopause. It may take several days or even weeks before you notice an improvement. You will only be prescribed Ovestin if your symptoms seriously hinder your daily life. In addition to the above uses, Ovestin Tablets may also be prescribed to treat certain forms of infertility, improve wound healing in postmenopausal women undergoing vaginal surgery or help assess cervical smears taken from postmenopausal women. A doctor's prescription is required to obtain this medicine. This medicine is 完全なドキュメントを読む
1 AUSTRALIAN PRODUCT INFORMATION OVESTIN (ESTRIOL) TABLETS 1 NAME OF THE MEDICINE Ovestin ® Tablets 1 mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Tablets, each containing 1 mg oestriol. Ovestin Tablets 1 mg are white, round, flat, scored tablets, with bevelled edges. All tablets are coded "DG" above "7" below the score line on one side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS • Short-term treatment of menopausal syndrome. Review the need for continuation of treatment after 6 months treatment, taking into account the risk- benefit ratio for the individual user at that moment (including cardiovascular disease and breast cancer, refer to SECTION 4.4 SPECIAL WARNING AND PRECAUTIONS FOR USE). Ovestin tablets should only be continued for as long as the benefit outweighs the risks. 4.2 D OSE AND METHOD OF ADMINISTRATION Ovestin is an oestrogen-only product that may be given to women with or without a uterus. • Ovestin tablets should be taken orally and swallowed with some water or other drink, preferably at the same time every day. • When initiating therapy, depending on the severity of the symptoms, a daily dosage of up to 4 mg (4 tablets) will usually be required. This dosage should be given in the first 5 to 7 days and can then be reduced to the maintenance level (1 to 2 mg daily, i.e. 1 to 2 tablets) in the course of the following 1 to 3 weeks depending on the degree of patient response. The lowest dose which will control the symptoms should be used. • Oestriol tablets should be prescribed for the shortest duration consistent with treatment goals. Review the need for continuation of treatment at least every 6 months, taking into account the risk-benefit ratio for the individual user at 2 that moment (refer to SECTION 4.4 SPECIAL WARNING AND PRECAUTIONS FOR USE and SECTION 4.1 THERAPEUTIC INDICATIONS). 完全なドキュメントを読む